IRIS Accounts Production v26.2.0.496 04409735 Board of Directors 1.7.25 30.6.26 30.6.26 6/10/2026 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh044097352025-06-30044097352026-06-30044097352025-07-012026-06-30044097352024-06-30044097352024-07-012025-06-30044097352025-06-3004409735ns15:EnglandWales2025-07-012026-06-3004409735ns14:PoundSterling2025-07-012026-06-3004409735ns10:Director12025-07-012026-06-3004409735ns10:PrivateLimitedCompanyLtd2025-07-012026-06-3004409735ns10:SmallEntities2025-07-012026-06-3004409735ns10:Audited2025-07-012026-06-3004409735ns10:SmallCompaniesRegimeForDirectorsReport2025-07-012026-06-3004409735ns10:SmallCompaniesRegimeForAccounts2025-07-012026-06-3004409735ns10:FullAccounts2025-07-012026-06-3004409735ns10:Director22025-07-012026-06-3004409735ns10:CompanySecretary12025-07-012026-06-3004409735ns10:RegisteredOffice2025-07-012026-06-3004409735ns5:CurrentFinancialInstruments2026-06-3004409735ns5:CurrentFinancialInstruments2025-06-3004409735ns5:ShareCapital2026-06-3004409735ns5:ShareCapital2025-06-3004409735ns5:RetainedEarningsAccumulatedLosses2026-06-3004409735ns5:RetainedEarningsAccumulatedLosses2025-06-3004409735ns5:LeaseholdImprovements2025-06-3004409735ns5:PlantMachinery2025-06-3004409735ns5:ComputerEquipment2025-06-3004409735ns5:LeaseholdImprovements2025-07-012026-06-3004409735ns5:PlantMachinery2025-07-012026-06-3004409735ns5:ComputerEquipment2025-07-012026-06-3004409735ns5:LeaseholdImprovements2026-06-3004409735ns5:PlantMachinery2026-06-3004409735ns5:ComputerEquipment2026-06-3004409735ns5:LeaseholdImprovements2025-06-3004409735ns5:PlantMachinery2025-06-3004409735ns5:ComputerEquipment2025-06-3004409735ns5:WithinOneYearns5:CurrentFinancialInstruments2026-06-3004409735ns5:WithinOneYearns5:CurrentFinancialInstruments2025-06-3004409735ns5:WithinOneYear2026-06-3004409735ns5:WithinOneYear2025-06-3004409735ns5:BetweenOneFiveYears2026-06-3004409735ns5:BetweenOneFiveYears2025-06-3004409735ns5:AllPeriods2026-06-3004409735ns5:AllPeriods2025-06-30
REGISTERED NUMBER: 04409735 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2026

FOR

PASANTE HEALTHCARE LIMITED

PASANTE HEALTHCARE LIMITED (REGISTERED NUMBER: 04409735)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PASANTE HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2026







DIRECTORS: M K Goh
L K Goh





SECRETARY: M K Goh





REGISTERED OFFICE: 15 West Street
Brighton
East Sussex
BN1 2RL





REGISTERED NUMBER: 04409735 (England and Wales)





AUDITORS: Galloways Accounting (Audit) Limited
Statutory Auditors
15 West Street
Brighton
East Sussex
BN1 2RL

PASANTE HEALTHCARE LIMITED (REGISTERED NUMBER: 04409735)

BALANCE SHEET
30 JUNE 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 265,703 344,859

CURRENT ASSETS
Stocks 5 2,349,877 1,736,310
Debtors 6 1,272,425 1,406,110
Cash at bank and in hand 968,348 942,417
4,590,650 4,084,837
CREDITORS
Amounts falling due within one year 7 2,353,775 2,330,158
NET CURRENT ASSETS 2,236,875 1,754,679
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,502,578

2,099,538

PROVISIONS FOR LIABILITIES 63,483 52,764
NET ASSETS 2,439,095 2,046,774

CAPITAL AND RESERVES
Called up share capital 253 253
Retained earnings 2,438,842 2,046,521
2,439,095 2,046,774

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 October 2026 and were signed on its behalf by:





M K Goh - Director


PASANTE HEALTHCARE LIMITED (REGISTERED NUMBER: 04409735)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2026


1. STATUTORY INFORMATION

Pasante Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in Sterling (£) and rounded to the nearest £1.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group of which this company is a part of.

Turnover
Turnover is recognised at the point the goods are dispatched to the customer. Where the goods are packed and allocated to a specific customer ready for collection or delivery and the company has done everything necessary to transfer the risks and rewards of ownership, the revenue is also recognised. It is included in the financial statements net of value added tax.

Tangible fixed assets
Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful
life.

Improvements to propertyover the period of the lease
Plant and machineryover a period between 2 and 10 years
Computer equipmentover a period between 3 and 5 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The company applies Sections 11 and 12 of FRS 102. Basic financial assets, comprising trade and other debtors and cash, and basic financial liabilities, comprising trade and other creditors and amounts owed to group undertakings, are initially recognised at transaction price and subsequently measured at amortised cost. Balances that are short term and non-interest bearing are measured at the undiscounted amount expected to be received or paid. Financial assets are assessed for impairment at each reporting date, and any impairment losses or reversals are recognised in profit or loss.

Financial instruments are offset and the net amount reported in the balance sheet when there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis or realise the asset and settle the liability simultaneously.


PASANTE HEALTHCARE LIMITED (REGISTERED NUMBER: 04409735)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2026


2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. All assets are depreciated over their estimated useful lives.

The interest element of these obligations is charged to the profit and loss account over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 40 (2025 - 42 ) .

PASANTE HEALTHCARE LIMITED (REGISTERED NUMBER: 04409735)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2026


4. TANGIBLE FIXED ASSETS
Improvements
to Plant and Computer
property machinery equipment Totals
£    £    £    £   
COST
At 1 July 2025 730,063 410,308 140,895 1,281,266
Additions - 14,197 18,949 33,146
At 30 June 2026 730,063 424,505 159,844 1,314,412
DEPRECIATION
At 1 July 2025 472,227 340,155 124,025 936,407
Charge for year 83,473 14,561 14,268 112,302
At 30 June 2026 555,700 354,716 138,293 1,048,709
NET BOOK VALUE
At 30 June 2026 174,363 69,789 21,551 265,703
At 30 June 2025 257,836 70,153 16,870 344,859

5. STOCKS
2026 2025
£    £   
Stocks 2,349,877 1,736,310

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 1,047,415 1,173,755
Other debtors 56,040 50,222
Prepayments 168,970 182,133
1,272,425 1,406,110

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade creditors 303,601 385,489
Amounts owed to group undertakings 443,743 594,031
Tax 112,185 34,325
Social security and other taxes 46,404 43,912
VAT 226,254 144,622
Other creditors 428,314 560,866
Accrued expenses 793,274 566,913
2,353,775 2,330,158

PASANTE HEALTHCARE LIMITED (REGISTERED NUMBER: 04409735)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2026


8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2026 2025
£    £   
Within one year 224,000 224,000
Between one and five years 392,000 616,153
616,000 840,153

9. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Christian Heeger FCA BFP BSc (Senior Statutory Auditor)
for and on behalf of Galloways Accounting (Audit) Limited

10. RELATED PARTY DISCLOSURES

The company has taken advantage of the exemptions of Financial Reporting Standard 102 section 33.1A from disclosing transactions with fellow wholly owned group companies.

11. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Karex Berhad.

The Company's immediate parent company is Karex Holdings Sdn Bhd, a company incorporated in Malaysia. The Company's ultimate parent undertaking and controlling party is Karex Berhad, a corporation listed in Malaysia, which is the smallest and largest group for which consolidated accounts including Pasante Healthcare Limited are prepared. Copies of the group financial statements of Karex Berhad are available on the company website. The registered office for Karex Holdings Sdn Bhd is Lot 594, Persiaran Raja Lumu, Pandamaran Industrial Estate, Port Klang, Selangor Dural Ehsan, 42000.The registered office address of the ultimate parent Karex Berhad is 12th Floor, Menara Symphony, No. 5, Jalan Prof. Khoo Kay Kim, Seksyen 13, 46200 Petaling Jaya, Selangor Darul Ehsan, Malaysia